Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration
Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
|
LONG BEACH, Calif., January 27, 2006 - The Zuellig Group (ZG) today announced the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America. He will oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
"George has extensive experience across a diverse range of industries, and has been successful in building the companies he manages into world leaders in their respective markets," stated Bill Meaney, CEO, The Zuellig Group. "We are very pleased to have him join our team and feel that his strong and decisive leadership will have a tremendous positive impact on the company."
Pontiakos has held senior leadership positions at several leading consulting, medical services and technology companies including Monovasia, which he founded, Oluma, Lucent, Agere, Ortel, NetVantage and Timeplex. He has wide-ranging experience in scaling geographically dispersed global companies to maximize their ability to successfully compete in the marketplace. Pontiakos holds a Bachelor of Science degree in Business Management from Farleigh Dickinson University, New Jersey.
Zuellig Group Nutrition and Ingredients (ZGNI) is a leading manufacturer, marketer and distributor of value-added, premium quality, dietary supplement and food ingredients. The entities within the group include BI Nutraceuticals, Long Beach, CA, Premium Performance Ingredients, Islandia, NY and ZGNI China, Shanghai, China. ZGNI services the nutrition, food and healthcare industries worldwide.
# # # |